Publisher Correction: Cardiovascular Outcome Trials of Diabetes and Obesity Drugs: Implications for Conditional Approval and Early Phase Clinical Development

1 Publisher Correction: Pharm Med https://doi.org/10.1007/s40290-017-0209-3

The original version of this article unfortunately contained a mistake. Table 1 was presented incorrectly. The corrected Table 1 is given below.

Table 1 MACE primary composite endpoints applied in diabetes CVOTs to date